W. Brandon Ingersoll
Brandon is one of the founding partners of MedEquity Capital. While at MedEquity he has sourced, managed and run a number of the firm’s investments in the specialty pharmacy, OTC medications and outsourcing sectors. He currently serves as the Operating Chairman of PharmaLogic. In that role, he has sourced and closed over 33 pharmacy acquisitions on their behalf. PharmaLogic has grown to become the largest independent radiopharmacy in North America during his tenure as Chairman. His other board and operating roles include Operating Chairman for Belmar Pharma Solutions and CEO of LiceGuard, LLC.
Prior to MedEquity, he worked in the healthcare group at Bain & Company. Brandon also was previously the Product Marketing Manager of Health Payment Review, a leading HCIT software provider to payors backed by Greylock Capital, just after they were acquired by McKesson. He has a degree in economics from Brigham Young University (Magna Cum Laude), an MBA from the Harvard Business School and is a member of the Phi Beta Kappa honor society. When not at work he enjoys mountain biking, skiing, kayaking and playing guitar.
Jeffrey T. Ward
Jeff is one of the founding partners of MedEquity Capital. Jeff has significant experience with physician-oriented business models as well as technology enabled healthcare service businesses. Jeff is currently the CEO and Chairman of AppleCare Immediate Care. AppleCare operates a dozen urgent care centers in South and middle Georgia. Jeff has also served as the CEO of Tristan Medical, an operator of primary care and urgent care centers in Massachusetts. Jeff has also held other active roles at MedEquity’s investment companies including CFO and development officer. Jeff has served as a director of LeadScope, Inc., VelQuest Corporation, OnCure Medical Corp., AppleCare Immediate Care, LiceGuard, Tristan Medical, Interior Resources, and Qler Solutions.
Prior to joining MedEquity, Jeff was a Vice President in the Healthcare Investment Banking Group of PaineWebber Incorporated. While at PaineWebber, he executed over $4 billion in financing and merger and acquisition advisory transactions for a broad range of companies across the healthcare services and life sciences sectors. Prior to joining PaineWebber, he was a Vice President of Acadian Asset Management, a quantitative international equity investment management firm in Boston.
Jeff is a graduate of Colby College and the Darden School of Business Administration at the University of Virginia. He is also a Chartered Financial Analyst (CFA) and a member of the CFA Institute. While not working, Jeff enjoys skiing, sailing, playing platform tennis, and working on old cars.
Tom joined MedEquity Capital as a Vice President in 2016 and has since been promoted to Principal. His primary responsibilities include sourcing and executing new platform investments, as well as working with portfolio company management teams to plan and execute on their respective growth strategies.
Prior to MedEquity, Tom worked in both corporate and advisory arenas, most recently at Vertex Pharmaceuticals, a Boston-based biotechnology firm which develops and commercializes novel drug therapies, most notably those for the treatment of Cystic Fibrosis. At Vertex, Tom managed all financial and valuation exercises used by senior leadership for optimal decisions on mergers and acquisitions, licensing and strategic initiatives. In addition to Cystic Fibrosis, Tom evaluated opportunities within HCV, autoimmune diseases and influenza. Prior to Vertex, Tom was a valuation consultant at Duff & Phelps, now Kroll, where he managed client engagements for strategic, financial and tax purposes across a myriad of industry verticals.
Tom has a degree in Finance from Boston College (Magna Cum Laude) and an MBA from the Harvard Business School. He is also a Chartered Financial Analyst (CFA) and a member of both the CFA Institute and CFA Society Boston. While not working, he enjoys spending time with his wife and two young boys, golfing and reading.